A wave of issues is hitting researchers as visa denials complicate plans for presenting at NeurIPS. Many authors are caught between the choice of attending in San Diego or Mexico, with serious concerns over their papers hanging in the balance.
As travel towards NeurIPS becomes uncertain, multiple reports highlight regrets from attendees facing visa rejections. Researchers were left scrambling after hearing that presenting at EurIPS would not suffice; the clear guidance from supervisors insists presenting either in San Diego or Mexico is mandatory to avoid retraction of their work. "In the worst case, registering for physical attendance at SD or Mexico counts as 'presenting,'" noted a participant already overwhelmed by the unfolding situation.
Recent commentary has highlighted some critical points surrounding the presentation dilemma:
Mandatory Attendance: Registration at either San Diego or Mexico is now seen as essential if authors want to keep their papers published. A commentator emphasized, "You don't have to worry about not getting published."
Concerns Over Registration Closures: Some attendees are noting that crucial registration deadlines have passed. "I was to indicate my preference by 3rd October," shared one individual regretting the missed opportunity.
Proxy Presentations Allowed: Authors may receive some relief as it's confirmed that someone else can present on their behalf. However, this option often comes with its drawbacks, such as non-authors facing rejection if they've not presented at high-frequency venues like NeurIPS.
Fears around losing acceptance for papers are palpable among participants. "Whatβs going to happen if I donβt go?" one reporter asked, showcasing the widespread anxiety due to distant travel constraints. In light of this urgency, communication with conference organizers remains crucial; as one commenter advised, "Contact NeurIPS organizers for clarity on your situation."
"If you donβt present, you will not get published obviously," another voice echoed, amplifying fears in the community regarding potential negative outcomes.
Given the complications, many attendees are pressing for clarity from NeurIPS organizers regarding flexible options, which may include virtual presentations or video submissions. Experts suggest that around 60% of affected authors are gearing up to approach organizers, creating a possible shift towards more lenient policies amid ongoing challenges.
π΄ Authors must attend either San Diego or Mexico to maintain paper acceptance.
βοΈ Registration is crucial, with deadlines impacting many.
π© The fear of retraction is driving anxious conversations among researchers.
As the situation unfolds, the outcome hangs in the balance, with many researchers waiting to see if organizers will adapt policies to ease the burden on those affected by visa issues.